×
Chemed Cash on Hand 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed cash on hand for the quarter ending December 31, 2024 was
$0.178B
, a
32.43% decline
year-over-year.
Chemed cash on hand for 2024 was
$0.178B
, a
32.43% decline
from 2023.
Chemed cash on hand for 2023 was
$0.264B
, a
256.09% increase
from 2022.
Chemed cash on hand for 2022 was
$0.074B
, a
125.34% increase
from 2021.
View More
Chemed Cash on Hand 2010-2024 | CHE
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Chemed cash on hand for 2024 was
$0.178B
, a
32.43% decline
from 2023.
Chemed cash on hand for 2023 was
$0.264B
, a
256.09% increase
from 2022.
Chemed cash on hand for 2022 was
$0.074B
, a
125.34% increase
from 2021.
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.5B
Quest Diagnostics (DGX)
$19.2B
DaVita (DVA)
$12.4B
Encompass Health (EHC)
$10.2B
Elanco Animal Health (ELAN)
$5.6B
Option Care Health (OPCH)
$5.5B
RadNet (RDNT)
$4.8B
LifeStance Health (LFST)
$3.1B
Amedisys (AMED)
$3B
Astrana Health (ASTH)
$2.2B
Addus HomeCare (ADUS)
$2.1B
U.S Physical Therapy (USPH)
$1.3B
Aveanna Healthcare Holdings (AVAH)
$968M
Pennant (PNTG)
$927M
Atai Life Sciences (ATAI)
$351M
Bioqual (BIOQ)
$54M
Daxor (DXR)
$35M
Ontrak (OTRK)
$7M
MEDIROM Healthcare Technologies (MRM)
$4M
IMAC Holdings (BACK)
$1M
Psychemedics (PMD)
$0M